Compounds > phosphorylcholine

phosphorylcholine and 1,2-dioleoyloxy-3-(trimethylammonium)propane

phosphorylcholine has been researched along with 1,2-dioleoyloxy-3-(trimethylammonium)propane in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthélémy, P; Grinstaff, MW; Li, Y; Luo, D; Moreau, L; Prata, CA1
Aoshi, T; Haseda, Y; Koyama, S; Kumanogoh, A; Machiyama, H; Maruyama, K; Meng, J; Munakata, L; Naito, Y; Okada, Y; Omata, D; Osa, A; Suzuki, R; Tanimoto, Y; Yoshioka, Y1

Other Studies

2 other study(ies) available for phosphorylcholine and 1,2-dioleoyloxy-3-(trimethylammonium)propane

ArticleYear
Nucleoside phosphocholine amphiphile for in vitro DNA transfection.
    Molecular bioSystems, 2005, Volume: 1, Issue:3

    Topics: Animals; beta-Galactosidase; CHO Cells; Cricetinae; DNA; Fatty Acids, Monounsaturated; Genes, Reporter; Indicators and Reagents; Microscopy, Electron; Phosphorylcholine; Plasmids; Quaternary Ammonium Compounds; Recombinant Proteins; Transfection; Uridine; X-Ray Diffraction

2005
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 11-10, Volume: 313

    Topics: Animals; Antineoplastic Agents; Blood Cells; CD8-Positive T-Lymphocytes; Drug Compounding; Drug Stability; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Humans; Immunosuppression Therapy; Immunotherapy; Lipids; Liver; Mice; Nanocapsules; Neoplasms; Neoplasms, Experimental; Oligodeoxyribonucleotides; Phosphatidylethanolamines; Phosphorylcholine; Programmed Cell Death 1 Receptor; Quaternary Ammonium Compounds; Tumor Microenvironment

2019